Project netboard - Collaborative project online management tool - Horizon Europe - ADEME - BPI
Description: a pivotal phase III study will be conducted, and regulatory filing for market authorization of the therapy in EU and USA will be made by 2019.
project netboard (20) absiskey (17) ataxia telangiectasia (1) rare genetic disease (1) iedat (1) erydel (1) pivotal phase iii study (1) h2020; clinical study (1) h2020; clinical study
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed in mollis sem, nec luctus ligula. Duis ullamcorper turpis ac purus pretium lacinia non ut metus. Nunc scelerisque urna mollis neque tristique rutrum. Aenean metus turpis, hendrerit id porta non, viverra ut felis. Etiam ultricies vulputate quam vitae molestie. Mauris a fermentum turpis. Donec leo nisi, porttitor et rhoncus vitae, dictum vitae arcu. Etiam tincidunt accumsan arcu, et pellentesque lorem. Nullam lobortis turpis at scelerisque dapibus.
Phasellus ac ultrices justo. Donec in dui viverra, sodales ligula sit amet, iaculis tortor. Aenean dignissim nisl a elementum mattis. Duis venenatis et eros nec laoreet. Fusce eu sodales nulla, euismod eleifend ligula. Sed augue eros, faucibus nec leo id, pulvinar dapibus quam. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Sed et mi mauris. Duis cursus enim mauris, faucibus vehicula lacus ullamcorper at.
EU Funding for development of EDS for the treatment of Ataxia Telangiectasia (AT).On behalf of the IEDAT Consortium, EryDel SpA announced the award of a...
Project netboard - Collaborative project online management tool - Horizon Europe - ADEME - BPI